Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v2-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-11-18 | 2025-10-01 |
| Drug Identification Number | 02439379 | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2mg/mL, 100 mL BAG | ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2mg/mL, 100 mL BAG |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 100 mL | 100 mL |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2025-10-10 | |
| Actual start date | 2025-10-01 | |
| Estimated end date | 2025-12-15 | 2025-12-15 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | Yes | No |
| Company comments | Fresenius Kabi Canada regrets to advise that, due to an increase in demand, we will be encountering a supply interrup-tion on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 100 mL Bag, effective October 1, 2025, until December 15, 2025. | Fresenius Kabi Canada regrets to advise that, due to an increase in demand, we will be encountering a supply interrup-tion on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 100 mL Bag, effective October 1, 2025, until December 15, 2025. |
| Health Canada comments |